Sign up to our newsletter Subscribe
Understanding societal preferences for priority by disease severity in England & Wales
< 1 min read|01/08/1999
Risk and Return in the Pharmaceutical Industry
This book has been built up from the papers delivered at the Office of Health Economics conference which took place at the Langham Hilton Hotel, London, on 5 December 1996.
The speakers assembled for this symposium represent important contributors to the economic analysis…
This book has been built up from the papers delivered at the Office of Health Economics conference which took place at the Langham Hilton Hotel, London, on 5 December 1996.
The speakers assembled for this symposium represent important contributors to the economic analysis of the risks inherent in pharmaceutical research and development (R&D) and the returns achieved by it. Together these authors bring to this analysis a unique combination of academic rigour and detailed knowledge of industry practice. The result is a series of telling insights into the peculiar characteristics of the risk/return trade-offs intrinsic to R&D in the pharmaceutical industry.
Risk and Return in the Pharmaceutical Industry
Sussex, J. and Marchant, N. ed.
(1999) Risk and Return in the Pharmaceutical Industry. OHE Monograph. Available from https://www.ohe.org/publications/risk-and-return-pharmaceutical-industry/
